This is a resource page for haemato-oncology. These resources have been established in line with Recommendation 24* of the National Cancer Strategy (2017-2026)*. They have been developed collaboratively under the governance of the NCCP National Haemato-oncology Clinical Leads Group.
* The NCCP will develop appropriate MDT, centralisation and treatment arrangements to meet the diverse needs of patients with haematological cancers.
The following resources are linked below:
- NCCP Haematology Referral Information Manual Adult
- NCCP Service Specification for Haemato-oncology Services (PDF, 1.4 KB, 21 pages)
- Haemato-oncology Tumour Conference SOP (PDF, 1.1 MB, 17 pages)
- Systemic Anti-Cancer Therapy Patient Consent Form – Haemato-oncology (Word, 55 KB, 2 pages)
NCCP National Haemato-oncology Adult Patient Pathways
- Acute Lymphoblastic Leukaemia (ALL) / Acute Lymphoblastic Lymphoma (LBL) (PDF, 456 KB, 16 pages)
- Acute Myeloid Leukaemia (AML) (PDF, 451 KB, 17 pages)
- High Grade Lymphoma (PDF, 497 KB, 19 pages)
- Low Grade Lymphoma (PDF, 464 KB, 18 pages)
- Multiple Myeloma (PDF, 484 KB, 17 pages)
- NCCP National Framework for Patient Pathways (PDF, 561 KB, 23 pages)